Advanced Tumor Detection and Diagnosis Based on Biomarker
A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensors and Healthcare".
Deadline for manuscript submissions: closed (1 September 2022)
Special Issue Editor
Interests: chemicobiology; pharmacochemistry; multi-omics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Tumors are the second-largest cause of mortality in the world. The early detection and diagnosis of a tumor can effectively reduce its occurrence and fatality rate. Cancer biomarkers are molecules that are present in human blood, urine, or saliva as well as in other bodily fluids, tissues, and cells that are used to identify various tumors and to monitor tumor progression. The discovery of tumor biomarkers, namely nucleic acids, proteins, small-molecule metabolites, and microorganisms, can be applied to the detection, diagnosis, and prognosis of tumors because of their high sensitivity and specificity and non-invasive nature. Furthermore, the development of novel, simple, highly sensitive, and specific biomarker detection techniques is also significant for the use of biomarkers in tumor detection. Therefore, this new Special Issue focuses on the publication of scientific papers about tumor-related biomarkers as well as novel analytical methods and technologies for cancer detection.
We kindly invite the submission of original research and review articles about novel tumor biomarkers and biosensor technologies for tumor detection, diagnosis, prognosis, and monitoring.